Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/GlycoVaxyn

GlycoVaxyn

Series B
SwitzerlandMar 2009
Healthtech

GlycoVaxyn raised €17M in a Series B round in Mar 2009. The company is based in Switzerland. Investors in the round: Edmond de Rothschild Venture Capital, Index Ventures, Sofinnova Partners. Data as of Nov 2026.

← GlycoVaxyn
Amount raised
€17M
€16,845,935
Native amount
21,300,000 USD
Stage
Series B
series b
Investors
3

Provenance & confidence

Unverified
Amount
21,300,000 USD
ECB-at-date → €17M · rate 1.2644 on 2009-02-27
High confidence
Source

No source on record — unverified.

Unverified

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

3 named
Edmond de Rothschild Venture CapitalIndex VenturesSofinnova Partners
Date
Mar 2009
Round type
series b
Amount (EUR)
€17M

Other rounds

same company